Q-Line Biotech IPO GMP
Listed
Historical GMP record
Grey market premium history vs actual listing price
Q-Line Biotech IPO's final recorded GMP before listing was ₹110 per share (a 32% premium over the ₹343 upper price band). The shares listed at ₹452. GMP is unofficial and does not forecast or guarantee the actual listing price.
Q-Line Biotech IPO GMP vs actual listing price
The indicative price was a grey-market calculation, not a forecast. The actual listing price is determined on the exchange and can differ materially from GMP-based figures.
Q-Line Biotech IPO GMP history (day-wise)
Last recorded grey-market quote for each day, newest first. Across the recorded period, Q-Line Biotech IPO GMP ranged from ₹20 to ₹110.
| Date | GMP (₹) | Change | GMP % | Indicative Listing (₹) = upper price band + GMP. Indicative only, not a forecast. |
|---|---|---|---|---|
| +₹110 | +₹10 | +32% | ₹453 | |
| +₹100 | +₹5 | +29% | ₹443 | |
| +₹95 | ₹0 | +28% | ₹438 | |
| +₹95 | −₹7 | +28% | ₹438 | |
| +₹102 | +₹2 | +30% | ₹445 | |
| +₹100 | ₹0 | +29% | ₹443 | |
| +₹100 | ₹0 | +29% | ₹443 | |
| +₹100 | +₹15 | +29% | ₹443 | |
| +₹85 | +₹40 | +25% | ₹428 | |
| +₹45 | — | +13% | ₹388 |
Q-Line Biotech IPO details
| Price Band | ₹326-343 |
|---|---|
| Lot Size | 400 shares |
| Issue Size | 62,53,200 shares(agg. up to ₹214.48 Cr) |
| Listing At | NSE SME |
| Open Date | May 21, 2026 |
| Close Date | May 25, 2026 |
| Allotment Date | May 26, 2026 |
| Listing Date | May 29, 2026 |
How IPO Ji updates GMP data
- Source: GMP figures come from IPO Ji's informal-market data feed and are not exchange-published prices.
- Calculation: GMP % = GMP ÷ upper price band × 100. Indicative listing price = upper price band + GMP.
- Freshness: Timestamps are shown in IST and the page reflects the most recently recorded quote. A value without a reliable timestamp is not labelled “today” or “current”.
- Editorial policy: IPO Ji reports the recorded figure without ranking IPOs or recommending an application decision.
GMP can change without notice and may differ materially from the actual listing price.
FAQs
Q-Line Biotech IPO GMP — Frequently Asked Questions
What was Q-Line Biotech IPO GMP before listing?
Q-Line Biotech IPO's final recorded GMP before listing was ₹110 per share (a 32% premium over the ₹343 upper price band). The shares listed at ₹452. GMP is unofficial and does not forecast or guarantee the actual listing price.
What is the indicative listing price of Q-Line Biotech IPO?
The indicative listing price of Q-Line Biotech IPO was ₹453, calculated as the ₹343 upper price band + ₹110 GMP. This figure is based on unofficial grey-market quotes; it is indicative only and not a forecast or guarantee of the actual listing price.
Is Q-Line Biotech IPO GMP a guarantee of the listing price?
No. GMP is unofficial, unregulated grey-market information and does not forecast or guarantee the actual listing price of Q-Line Biotech IPO. It can change quickly and may differ materially from the eventual exchange price. IPO Ji reports it for information only and does not deal in or facilitate grey-market transactions.
When will Q-Line Biotech IPO list?
Q-Line Biotech IPO has listed on May 29, 2026 on NSE SME. The shares listed at ₹452.
How often is Q-Line Biotech IPO GMP updated?
The Q-Line Biotech IPO GMP on this page refreshes whenever a new grey-market figure is recorded in IPO Ji's data feed; the latest recorded quote is from 28 May 2026, 10:30 PM IST. Because the grey market is informal, figures are indicative and can change through the day.